Expression of Hypoxia-related Tissue Factors Correlates with Diminished Survival of Adjuvantly Treated Patients with Chromosome 1p Aberrant Oligodendroglial Neoplasms and Therapeutic Implications
- 1 October 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (19), 6567-6571
- https://doi.org/10.1158/1078-0432.ccr-04-0617
Abstract
Purpose: Oligodendroglial neoplasms with chromosome 1p deletion are chemosensitive, and stratified adjuvant therapies have been proposed on the basis of 1p status. In this study, we evaluated expression of hypoxia-related factors and its influence on survival in oligodendroglial brain tumors with chromosome 1p aberrations. Experimental Design: Forty-four primary and 16 recurrent oligodendroglial neoplasms with 1p aberrations (deletion or imbalance) were investigated immunohistochemically for expression of hypoxia-inducible factor 1α and carbonic anhydrase-9. We used in situ hybridization to investigate expression of vascular endothelial growth factor-mRNA. We defined as “low hypoxia score” expression of no or only one marker and as “high hypoxia score” expression of two or three markers. The predominant vascular patterns of tumors were defined as classic or bizarre vascular formations, based on anti-CD34–immunostaining. Results: High hypoxia score was evident in 16 of 44 (36.4%) primary tumor specimens and in 14 of 16 (87.5%) recurrent tumors (P = 0.001). High hypoxia score was associated with the presence of bizarre vascular proliferations and WHO grade III. In the subgroup of patients who received adjuvant therapy, univariate analysis showed significantly shorter survival of patients with high hypoxia score (n = 27; P = 0.0145). For all of the primary tumors, hypoxia score was an independent prognostic factor (P = 0.045). Conclusions: A fraction of oligodendroglial neoplasms with 1p aberrations shows evidence of tissue hypoxia, which significantly influences survival of patients receiving adjuvant therapy. Evaluation of tissue hypoxia could become useful for recruitment of patients for individualized therapy strategies, e.g., selection of patients with hypoxic tumors for hyperbaric oxygenation preceding radiotherapy.Keywords
This publication has 16 references indexed in Scilit:
- Fluorescent In Situ Hybridization on Isolated Tumor Cell Nuclei: A Sensitive Method for 1p and 19q Deletion Analysis in Paraffin-Embedded Oligodendroglial Tumor SpecimensLaboratory Investigation, 2003
- Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic SubtypesBrain Pathology, 2003
- DEC1 (STRA13) protein expression relates to hypoxia‐ inducible factor 1‐alpha and carbonic anhydrase‐9 overexpression in non‐small cell lung cancerThe Journal of Pathology, 2003
- Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomasInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Characterization and validation of noninvasive oxygen tension measurements in human glioma xenografts by 19F-MR relaxometryInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Molecular analysis of chromosomh 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumorsInternational Journal of Cancer, 1994
- In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brainActa Neuropathologica, 1992
- Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivoNature, 1992
- Intratumoral oxygen pressure in malignant brain tumorJournal of Neurosurgery, 1991